{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:21:37Z","timestamp":1790238097880,"version":"4.1.0"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T00:00:00Z","timestamp":1539648000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2018.01185","type":"journal-article","created":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T04:32:18Z","timestamp":1539664338000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":29,"title":["Potentiation of Glutamatergic Synaptic Transmission Onto Dorsal Raphe Serotonergic Neurons in the Valproic Acid Model of Autism"],"prefix":"10.3389","volume":"9","author":[{"given":"Ruixiang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Hausknecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roh-Yu","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Haj-Dahmane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,10,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1186\/2040-2392-4-36","article-title":"SFARI Gene 2.0: a community-driven knowledgebase for the autism spectrum disorders (ASDs).","volume":"4","author":"Abrahams","year":"2013","journal-title":"Mol. Autism"},{"key":"B2","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nrg2346","article-title":"Advances in autism genetics: on the threshold of a new neurobiology.","volume":"9","author":"Abrahams","year":"2008","journal-title":"Nat. Rev. Genet."},{"key":"B3","doi-asserted-by":"publisher","year":"2013","journal-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-5<sup>\u00ae<\/sup>)","DOI":"10.1176\/appi.books.9780890425596"},{"key":"B4","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3378\/027.082.0303","article-title":"5-HTTLPR polymorphism: analysis in South African autistic individuals.","volume":"82","author":"Arieff","year":"2010","journal-title":"Hum. Biol."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2014.00387","article-title":"Abnormal emotional learning in a rat model of autism exposed to valproic acid in utero.","volume":"8","author":"Banerjee","year":"2014","journal-title":"Front. Behav. Neurosci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.bbr.2018.02.003","article-title":"The visible burrow system: a behavioral paradigm to assess sociability and social withdrawal in BTBR and C57BL\/6J mice strains.","volume":"344","author":"Bove","year":"2018","journal-title":"Behav. Brain Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1001\/jama.2013.2270","article-title":"Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism.","volume":"309","author":"Christensen","year":"2013","journal-title":"JAMA"},{"key":"B8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/0165-1781(94)90117-1","article-title":"Depressive and obsessive-compulsive symptoms in hyperserotonemic parents of children with autistic disorder.","volume":"52","author":"Cook","year":"1994","journal-title":"Psychiatry Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/BF02147990","article-title":"Localization of monoamines in the lower brain stem.","volume":"20","author":"Dahlstr\u00f6m","year":"1964","journal-title":"Cell. Mol. Life Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1093\/brain\/awu178","article-title":"Response inhibition and serotonin in autism: a functional MRI study using acute tryptophan depletion.","volume":"137","author":"Daly","year":"2014","journal-title":"Brain"},{"key":"B11","doi-asserted-by":"publisher","first-page":"12560","DOI":"10.1073\/pnas.0506071102","article-title":"Reduced cortical activity due to a shift in the balance between excitation and inhibition in a mouse model of Rett syndrome.","volume":"102","author":"Dani","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B12","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/cne.902070305","article-title":"The serotonin neurons in nucleus raphe dorsalis of adult rat: a light and electron microscope radioautographic study.","volume":"207","author":"Descarries","year":"1982","journal-title":"J. Comp. Neurol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1038\/sj.mp.4001724","article-title":"Autism and the serotonin transporter: the long and short of it.","volume":"10","author":"Devlin","year":"2005","journal-title":"Mol. Psychiatry"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2013.00088","article-title":"General developmental health in the VPA-rat model of autism.","volume":"7","author":"Favre","year":"2013","journal-title":"Front. Behav. Neurosci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1016\/j.freeradbiomed.2012.03.011","article-title":"Oxidative stress-related biomarkers in autism: systematic review and meta-analyses.","volume":"52","author":"Frustaci","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.euroneuro.2014.02.004","article-title":"Blood serotonin levels in autism spectrum disorder: a systematic review and meta-analysis.","volume":"24","author":"Gabriele","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.neuropharm.2015.02.027","article-title":"Time-dependent modulation of glutamate synapses onto 5-HT neurons by antidepressant treatment.","volume":"95","author":"Geddes","year":"2015","journal-title":"Neuropharmacology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/0163-7258(81)90081-4","article-title":"ACTH-induced excessive grooming in the rat.","volume":"12","author":"Gispen","year":"1981","journal-title":"Pharmacol. Ther."},{"key":"B19","doi-asserted-by":"publisher","first-page":"18620","DOI":"10.1073\/pnas.0509591102","article-title":"Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis.","volume":"102","author":"Gobbi","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2012.00118","article-title":"Environmental factors in autism.","volume":"3","author":"Grabrucker","year":"2013","journal-title":"Front. Psychiatry"},{"key":"B21","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0091-3057(95)02135-3","article-title":"Role of 5-HT in stress, anxiety, and depression.","volume":"54","author":"Graeff","year":"1996","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B22","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1046\/j.0953-816x.2001.01616.x","article-title":"D2-like dopamine receptor activation excites rat dorsal raphe 5-HT neurons in vitro.","volume":"14","author":"Haj-Dahmane","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1523\/ENEURO.0116-17.2017","article-title":"GluA2-Lacking AMPA receptors and nitric oxide signaling gate spike-timing\u2013dependent potentiation of glutamate synapses in the dorsal raphe nucleus.","volume":"4","author":"Haj-Dahmane","year":"2017","journal-title":"eNeuro"},{"key":"B24","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/0091-3057(95)02126-4","article-title":"A review of the validity and variability of the elevated plus-maze as an animal model of anxiety.","volume":"54","author":"Hogg","year":"1996","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B25","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1002\/ajmg.b.30720","article-title":"Autism and serotonin transporter gene polymorphisms: a systematic review and meta-analysis.","volume":"147","author":"Huang","year":"2008","journal-title":"Am. J. Med. Genet. Part B Neuropsychiatr. Genet."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1016\/0028-3908(84)90099-6","article-title":"5-HT and anxiety.","volume":"23","author":"Iversen","year":"1984","journal-title":"Neuropharmacology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ejphar.2004.11.054","article-title":"Mouse grooming microstructure is a reliable anxiety marker bidirectionally sensitive to GABAergic drugs.","volume":"508","author":"Kalueff","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2015.00017","article-title":"Suppression of NMDA receptor function in mice prenatally exposed to valproic acid improves social deficits and repetitive behaviors.","volume":"8","author":"Kang","year":"2015","journal-title":"Front. Mol. Neurosci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1111\/jnc.12147","article-title":"Male-specific alteration in excitatory post-synaptic development and social interaction in pre-natal valproic acid exposure model of autism spectrum disorder.","volume":"124","author":"Kim","year":"2013","journal-title":"J. Neurochem."},{"key":"B30","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/MOP.0b013e328336eb9a","article-title":"What causes autism? Exploring the environmental contribution.","volume":"22","author":"Landrigan","year":"2010","journal-title":"Curr. Opin. Pediatr."},{"key":"B31","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.biopsych.2016.05.011","article-title":"Excitation\/inhibition imbalance in animal models of autism spectrum disorders.","volume":"81","author":"Lee","year":"2017","journal-title":"Biol. Psychiatry"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2015.00094","article-title":"Shank3-mutant mice lacking exon 9 show altered excitation\/inhibition balance, enhanced rearing, and spatial memory deficit.","volume":"9","author":"Lee","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.bbr.2006.08.023","article-title":"Animal models of restricted repetitive behavior in autism.","volume":"176","author":"Lewis","year":"2007","journal-title":"Behav. Brain Res."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055248","article-title":"The amygdala excitatory\/inhibitory balance in a valproate-induced rat autism model.","volume":"8","author":"Lin","year":"2013","journal-title":"PLoS One"},{"key":"B35","doi-asserted-by":"publisher","first-page":"5443","DOI":"10.2174\/1381612820666140205150437","article-title":"Nitric oxide and teratogenesis: an update.","volume":"20","author":"Mario Tiboni","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"B36","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1038\/sj.npp.1301453","article-title":"Abnormal fear conditioning and amygdala processing in an animal model of autism.","volume":"33","author":"Markram","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"B37","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ijdevneu.2004.05.004","article-title":"Maternal administration of thalidomide or valproic acid causes abnormal serotonergic neurons in the offspring: implication for pathogenesis of autism.","volume":"23","author":"Miyazaki","year":"2005","journal-title":"Int. J. Dev. Neurosci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.neuroscience.2015.11.010","article-title":"The serotonin system in autism spectrum disorder: from biomarker to animal models.","volume":"321","author":"Muller","year":"2016","journal-title":"Neuroscience"},{"key":"B39","first-page":"576","article-title":"Increased monoamine concentration in the brain and blood of fetal thalidomide-and valproic acid\u2013exposed rat: putative animal models for autism.","volume":"52","author":"Narita","year":"2002","journal-title":"Pediatr. Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.expneurol.2017.04.017","article-title":"The valproic acid-induced rodent model of autism.","volume":"299","author":"Nicolini","year":"2018","journal-title":"Exp. Neurol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.neulet.2016.06.035","article-title":"Increased anxiety-like behaviour and altered GABAergic system in the amygdala and cerebellum of VPA rats\u2014An animal model of autism.","volume":"629","author":"Olexov\u00e1","year":"2016","journal-title":"Neurosci. Lett."},{"key":"B42","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.reprotox.2015.05.007","article-title":"Prenatal factors associated with autism spectrum disorder (ASD).","volume":"56","author":"Ornoy","year":"2015","journal-title":"Reprod. Toxicol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"13501","DOI":"10.1073\/pnas.0704391104","article-title":"Elevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid.","volume":"104","author":"Rinaldi","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/neuro.04.004.2008","article-title":"Hyper-connectivity and hyper-plasticity in the medial prefrontal cortex in the valproic acid animal model of autism.","volume":"2","author":"Rinaldi","year":"2008","journal-title":"Front. Neural Circuits"},{"key":"B45","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/S0149-7634(96)00058-9","article-title":"Anxiety, defence and the elevated plus-maze.","volume":"21","author":"Rodgers","year":"1997","journal-title":"Neurosci. Biobehav. Rev."},{"key":"B46","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ntt.2013.01.004","article-title":"In utero exposure to valproic acid and autism\u2014a current review of clinical and animal studies.","volume":"36","author":"Roullet","year":"2013","journal-title":"Neurotoxicol. Teratol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1034\/j.1601-183X.2003.00037.x","article-title":"Model of autism: increased ratio of excitation\/inhibition in key neural systems.","volume":"2","author":"Rubenstein","year":"2003","journal-title":"Genes Brain Behav."},{"key":"B48","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0022-3476(61)80261-8","article-title":"Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children.","volume":"58","author":"Schain","year":"1961","journal-title":"J. Pediatr."},{"key":"B49","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/sj.npp.1300518","article-title":"Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism.","volume":"30","author":"Schneider","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"B50","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.brainresbull.2012.01.011","article-title":"Prenatal exposure to valproic acid enhances synaptic plasticity in the medial prefrontal cortex and fear memories.","volume":"87","author":"Sui","year":"2012","journal-title":"Brain Res. Bull."},{"key":"B51","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/jcpp.12499","article-title":"Heritability of autism spectrum disorders: a meta-analysis of twin studies.","volume":"57","author":"Tick","year":"2016","journal-title":"J. Child Psychol. Psychiatry"},{"key":"B52","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.neures.2006.10.018","article-title":"Abnormality of circadian rhythm accompanied by an increase in frontal cortex serotonin in animal model of autism.","volume":"57","author":"Tsujino","year":"2007","journal-title":"Neurosci. Res."},{"key":"B53","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/0006-8993(83)90011-2","article-title":"Electrophysiological and pharmacological characterization of serotonergic dorsal raphe neurons recorded extracellularly and intracellularly in rat brain slices.","volume":"289","author":"Vandermaelen","year":"1983","journal-title":"Brain Res."},{"key":"B54","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.cpr.2009.01.003","article-title":"Anxiety in children and adolescents with autism spectrum disorders.","volume":"29","author":"White","year":"2009","journal-title":"Clin. Psychol. Rev."},{"key":"B55","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1523\/JNEUROSCI.08-09-03499.1988","article-title":"Voltage-and ligand-activated inwardly rectifying currents in dorsal raphe neurons in vitro.","volume":"8","author":"Williams","year":"1988","journal-title":"J. Neurosci."},{"key":"B56","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/nature10360","article-title":"Neocortical excitation\/inhibition balance in information processing and social dysfunction.","volume":"477","author":"Yizhar","year":"2011","journal-title":"Nature"},{"key":"B57","doi-asserted-by":"publisher","first-page":"587","DOI":"10.2174\/1871527315666160413121751","article-title":"Oxidative stress and nitric oxide in autism spectrum disorder and other neuropsychiatric disorders.","volume":"15","author":"Yui","year":"2016","journal-title":"CNS Neurol. Disord. Drug Targets"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2018.01185\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T04:32:21Z","timestamp":1539664341000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2018.01185\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,16]]},"references-count":57,"alternative-id":["10.3389\/fphar.2018.01185"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2018.01185","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,16]]},"article-number":"1185"}}